Related Experiment Video
Updated: Jun 17, 2026

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor
Van B T Ta1, Marjolein J W de Bruijn, Petra J ter Brugge
1Department of Immunology, Erasmus MC Rotterdam, Rotterdam, The Netherlands.
Abstract:
The adapter protein Slp65 is a key component of the precursor-B (pre-B) cell receptor. Slp65-deficient mice spontaneously develop pre-B cell leukemia, but the mechanism by which Slp65(-/-) pre-B cells become malignant is unknown. Loss of Btk, a Tec-family kinase that cooperates with Slp65 as a tumor suppressor, synergizes with deregulation of the c-Myc oncogene during lymphoma formation. Here, we report that the presence of the immunoglobulin heavy chain transgene V(H)81X prevented tumor development in Btk(-/-)Slp65(-/-) mice. This finding paralleled the reported effect of a human immunoglobulin heavy chain transgene on lymphoma development in Emu-myc mice, expressing transgenic c-Myc. Because activation of c-Myc strongly selects for spontaneous inactivation of the p19(Arf)-Mdm2-p53 tumor suppressor pathway, we investigated whether disruption of this pathway is a common alteration in Slp65(-/-) pre-B cell tumors. We found that combined loss of Slp65 and p53 in mice transformed pre-B cells very efficiently. Aberrations in p19(Arf), Mdm2, or p53 expression were found in all Slp65(-/-) (n = 17) and Btk(-/-)Slp65(-/-) (n = 32) pre-B cell leukemias analyzed. In addition, 9 of 10 p53(-/-)Slp65(-/-) pre-B cell leukemias manifested significant Mdm2 protein expression. These data indicate that malignant transformation of Slp65(-/-) pre-B cells involves disruption of the p19(Arf)-Mdm2-p53 tumor suppressor pathway.
Insights
The adapter protein Slp65 is crucial for preventing pre-B cell leukemia. Its absence leads to malignant transformation, often involving the p19(Arf)-Mdm2-p53 tumor suppressor pathway.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- The adapter protein Slp65 is essential for the precursor-B (pre-B) cell receptor function.
- Slp65-deficient mice develop pre-B cell leukemia, but the underlying mechanisms remain unclear.
- Btk kinase and c-Myc oncogene deregulation cooperate with Slp65 loss in lymphoma development.
Purpose of the Study:
- To investigate the mechanism of malignant transformation in Slp65-deficient pre-B cells.
- To determine the role of the p19(Arf)-Mdm2-p53 tumor suppressor pathway in Slp65-associated leukemia.
- To explore the impact of immunoglobulin heavy chain transgenes on tumor development.
Main Methods:
- Analysis of tumor development in Btk(-/-)Slp65(-/-) mice with immunoglobulin heavy chain transgenes.
- Investigation of the p19(Arf)-Mdm2-p53 pathway in Slp65(-/-) and Btk(-/-)Slp65(-/-) pre-B cell leukemias.
- Assessment of pre-B cell transformation efficiency in mice with combined Slp65 and p53 loss.
Main Results:
- The V(H)81X immunoglobulin heavy chain transgene prevented tumor development in Btk(-/-)Slp65(-/-) mice.
- Combined loss of Slp65 and p53 efficiently transformed pre-B cells.
- All analyzed Slp65(-/-) and Btk(-/-)Slp65(-/-) leukemias showed aberrations in the p19(Arf)-Mdm2-p53 pathway.
- A majority of p53(-/-)Slp65(-/-) leukemias exhibited significant Mdm2 protein expression.
Conclusions:
- Malignant transformation of Slp65(-/-) pre-B cells is strongly associated with disruption of the p19(Arf)-Mdm2-p53 tumor suppressor pathway.
- The p19(Arf)-Mdm2-p53 pathway is a critical component in the development of pre-B cell leukemia when Slp65 is absent.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle